Precigen, Inc. (PGEN)
4.32
+0.14
(+3.35%)
USD |
NASDAQ |
Jan 02, 10:25
Precigen EPS Diluted (Quarterly): -1.059 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| ADMA Biologics, Inc. | 0.1489 |
| Omeros Corp. | -0.4666 |
| GeoVax Labs, Inc. | -0.3115 |
| Vistagen Therapeutics, Inc. | -0.5432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -146.34M |
| Revenue (Quarterly) | 2.922M |
| Total Expenses (Quarterly) | 149.27M |
| Enterprise Value | 1.456B |
| Gross Profit Margin (Quarterly) | 53.70% |
| Profit Margin (Quarterly) | -5.01K% |
| Earnings Yield | -32.43% |
| Normalized Earnings Yield | -24.46 |